HDFC Pharma and Healthcare Fund Regular Growth
3Y Annualised
26.32%
-0.66% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
-9.14%
-0.66% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
2 years 12 months
11 years 4 months
9 years 7 months
Fund info
Fund size
₹3501.37 Cr
Min. SIP amount
₹100
Min. Lumpsum amount
₹100
Exit load
0%
In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment.
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
DSP Nifty Healthcare ETF
2nd
Nippon India Nifty Pharma ETF
3rd
DSP Healthcare Fund Direct Payout of Income Distribution cum capital withdrawal option
4th
DSP Healthcare Fund Direct Reinvestment of Income Distribution cum capital withdrawal option
5th
DSP Healthcare Fund Direct Growth
92nd
HDFC Pharma and Healthcare Fund Regular Growth
Fund Managers
About HDFC Pharma and Healthcare Fund Regular Growth
HDFC Pharma and Healthcare Fund Regular Growth is a Equity mutual fund scheme from HDFC Asset Management Co Ltd. This fund has been in existence for 3 years, having been launched on 2023-10-04. HDFC Pharma and Healthcare Fund Regular Growth has ₹3501.37 Cr worth of assets under management (AUM) as of Fri Oct 23 2026. The latest Net Asset Value (NAV) of HDFC Pharma and Healthcare Fund Regular Growth as of Wed Oct 21 2026 is ₹20.082. The fund has an expense ratio of 2.11%, which is medium comparable to most other Equity funds.
HDFC Pharma and Healthcare Fund Regular Growth returns for the last 1 year are 15.48%. Since launch, it has delivered 25.86% average annual returns.
The HDFC Pharma and Healthcare Fund Regular Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of HDFC Pharma and Healthcare Fund Regular Growth.
- Divi's Laboratories Ltd: 9.39%
- Sun Pharmaceuticals Industries Ltd: 8.28%
- Alkem Laboratories Ltd: 4.64%
- Cipla Ltd: 4.15%
- Apollo Hospitals Enterprise Ltd: 3.69%
AMC Information
| Name | HDFC Asset Management Co Ltd |
|---|---|
| Founding Date | 2023-10-04 |
| cliser@hdfcfund.com | |
| Phone | +91 22 66316333 |
| Website | www.hdfcfund.com |
| Address | HDFC Asset Management Company Limited,“HUL House”, 2nd Floor,,H.T. Parekh Marg,165-166, Backbay Reclamation,,Churchgate, |
Tax Implications of HDFC Pharma and Healthcare Fund Regular Growth
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from HDFC Asset Management Co Ltd
Alternative StrategiesArbitrage Fund
3Y CAGR
6.73%
expense ratio
2.04%
fund size
₹25407.18 Cr
Fixed IncomeGovernment Bond
3Y CAGR
5.68%
expense ratio
0.86%
fund size
₹1884.59 Cr
Fixed IncomeMedium to Long Duration
3Y CAGR
6.07%
expense ratio
1.36%
fund size
₹812.70 Cr
EquityEquity - Infrastructure
3Y CAGR
10.83%
expense ratio
1.33%
fund size
₹2250.53 Cr
AllocationFund of Funds
3Y CAGR
8.11%
expense ratio
0.34%
fund size
₹2646.85 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0
